DVAX – Dynavax Technologies Corporation

Dynavax Technologies Corporatio

DVAX

$10.31

Name : Dynavax Technologies Corporatio

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $1,279,172,096.00

EPSttm : 0.2

Dynavax Technologies Corporatio

$10.31

3.19%

$0.34

Float Short %

15.53

Margin Of Safety %

Put/Call OI Ratio

0.28

EPS Next Q Diff

0.04

EPS Last/This Y

0.12

EPS This/Next Y

0.2

Price

10.31

Target Price

24.75

Analyst Recom

1.8

Performance Q

-16.79

Relative Volume

1.22

Beta

1.31

Ticker: DVAX

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-20	DVAX	13.63	0.41	0.48	13839
2025-03-21	DVAX	13.82	0.41	0.00	13888
2025-03-24	DVAX	13.84	0.23	0.03	10563
2025-03-25	DVAX	13.95	0.23	0.00	10701
2025-03-26	DVAX	13.59	0.33	0.04	8043
2025-03-27	DVAX	13.72	0.33	0.16	8056
2025-03-28	DVAX	13.68	0.33	0.00	8169
2025-03-31	DVAX	12.95	0.33	0.15	8234
2025-04-01	DVAX	12.65	0.32	0.00	8479
2025-04-02	DVAX	12.87	0.32	0.03	8538
2025-04-03	DVAX	12.86	0.31	0.27	8700
2025-04-04	DVAX	12.63	0.31	0.01	8720
2025-04-07	DVAX	12.49	0.30	0.76	8965
2025-04-08	DVAX	11.75	0.30	0.01	9005
2025-04-09	DVAX	12.02	0.30	0.25	9184
2025-04-10	DVAX	10.97	0.29	0.42	9335
2025-04-11	DVAX	11.24	0.28	0.46	9473
2025-04-14	DVAX	11.44	0.28	4.50	9516
2025-04-15	DVAX	11.4	0.28	0.02	9521
2025-04-16	DVAX	10.65	0.28	5.55	9599
2025-04-17	DVAX	10.31	0.28	0.15	9601
2025-04-18	DVAX	10.31	0.28	0.09	9601
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-20	DVAX	13.62	164.3	-	0.32
2025-03-21	DVAX	13.81	164.3	-	0.32
2025-03-24	DVAX	13.84	164.3	-	0.32
2025-03-25	DVAX	13.98	164.3	-	0.32
2025-03-26	DVAX	13.58	164.3	-	0.32
2025-03-27	DVAX	13.72	164.3	-	0.32
2025-03-28	DVAX	13.68	164.3	-	0.32
2025-03-31	DVAX	12.95	164.3	-	0.32
2025-04-01	DVAX	12.71	164.3	-	0.32
2025-04-02	DVAX	12.87	164.3	-	0.32
2025-04-03	DVAX	12.86	164.3	-	0.32
2025-04-04	DVAX	12.62	164.3	-	0.32
2025-04-07	DVAX	12.49	164.3	-	0.32
2025-04-08	DVAX	11.75	164.3	-	0.32
2025-04-09	DVAX	12.03	164.3	-	0.32
2025-04-10	DVAX	10.98	164.3	-	0.32
2025-04-11	DVAX	11.25	164.3	-	0.32
2025-04-14	DVAX	11.44	164.3	-	0.32
2025-04-15	DVAX	11.41	164.3	-	0.32
2025-04-16	DVAX	10.64	164.3	-	0.32
2025-04-17	DVAX	10.31	138.1	-	0.33
2025-04-18	DVAX	10.31	138.1	-	0.33
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-20	DVAX	-0.56	-4.26	16.01
2025-03-21	DVAX	-0.80	-4.26	16.01
2025-03-24	DVAX	-0.80	-4.29	16.01
2025-03-25	DVAX	-0.80	-4.29	16.01
2025-03-26	DVAX	-0.97	-4.29	16.02
2025-03-27	DVAX	-0.97	-4.29	16.02
2025-03-28	DVAX	-0.97	-4.29	16.02
2025-03-31	DVAX	-0.97	-4.32	16.02
2025-04-01	DVAX	-0.97	-4.32	16.02
2025-04-02	DVAX	-0.97	-4.32	16.02
2025-04-03	DVAX	-0.97	-4.32	16.02
2025-04-04	DVAX	-0.97	-4.32	16.02
2025-04-07	DVAX	-0.97	-4.31	16.02
2025-04-08	DVAX	-0.97	-4.31	16.02
2025-04-09	DVAX	-0.97	-4.31	15.99
2025-04-10	DVAX	-0.97	-4.31	15.53
2025-04-11	DVAX	-0.97	-4.31	15.53
2025-04-14	DVAX	-0.97	-4.31	15.53
2025-04-15	DVAX	-0.97	-4.31	15.53
2025-04-16	DVAX	-0.97	-4.31	15.53
2025-04-17	DVAX	-0.97	-4.31	15.53
2025-04-18	DVAX	-0.97	-4.31	15.53
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.05

Avg. EPS Est. Current Quarter

0.04

Avg. EPS Est. Next Quarter

0.09

Insider Transactions

-0.97

Institutional Transactions

-4.31

Beta

1.31

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

11.48

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

51.8

Max Drawdown 5-Year %

-68.1

Target Price

24.75

P/E

59.02

Forward P/E

18.01

PEG

1.09

P/S

4.62

P/B

2.17

P/Free Cash Flow

21.3

EPS

0.17

Average EPS Est. Cur. Y

0.33

EPS Next Y. (Est.)

0.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.85

Relative Volume

1.22

Return on Equity vs Sector %

-15.4

Return on Equity vs Industry %

-3.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

Dynavax Technologies Corporatio

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 405

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Epidemic Preparedness Innovations; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; and Biological E. Limited. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

stock quote shares DVAX – Dynavax Technologies Corporation Stock Price stock today

news today DVAX – Dynavax Technologies Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch DVAX – Dynavax Technologies Corporation yahoo finance google finance

stock history DVAX – Dynavax Technologies Corporation invest stock market

stock prices DVAX premarket after hours

ticker DVAX fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

DVAX – Dynavax Technologies Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DVAX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y